Aspen Pharmacare Holdings Limited (JSE:APN) considers unsolicited offers for its active pharmaceutical ingredients operations Retail WriterAspen said it has received two unsolicited offers to buy parts of its global active pharmaceutical ingredients (API) business, which manufactures ingredients used in medications. Its share price leapt the most in more than four months. In a statement on September 9, 2021, Aspen said it would "embark on a structured process to facilitate offers for all or parts of its API business" before making a decision. Selling some of its API divisions could free up working capital to cut debt further or expand in other areas.